Professor | Jie Xiong | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Jie Xiong

Contact Information

jiexiong@whu.edu.cn

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	1996-2001 Bachelor in Clinical Medicine: Wuhan University 2001-2006 PhD in Pathogen Biology: Wuhan University
Work Experience	2023.12-Present Associate Professor, Department of Immunology, Tai Kang Medical College, Wuhan University 2006.07-2023.11 Lecturer, Department of Immunology, Tai Kang Medical College, Wuhan University 2016.01-2017.01 Visiting Scholar, Roswell Park Cancer Institute, USA 2007.09-2009.03 Visiting Scholar, Fukushima Medical University, Japan
Awards	Hubei Province Natural Science Award, Third Prize (Ranked 3rd)

University/Lab Affiliation and Title

Wuhan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

Work Experience

2023.12-Present Associate Professor, Department of Immunology, Tai Kang Medical College, Wuhan University
2006.07-2023.11 Lecturer, Department of Immunology, Tai Kang Medical College, Wuhan University
2016.01-2017.01 Visiting Scholar, Roswell Park Cancer Institute, USA
2007.09-2009.03 Visiting Scholar, Fukushima Medical University, Japan

Awards

Areas of Focus	Tumor targeted therapy Epigenetics and signaling pathways in cancer Identification of new therapeutic targets
Publications	Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer, Jie Xiong; Wei Zhang; Feng Li, 2024 Oncogenic BRAF noncanonically promotes tumor metastasis by mediating VASP phosphorylation and filopodia formation, Jie Xiong; Xin Zhu; Lei Wei; Feng Li, 2023 Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis, Jie Xiong; Feng Li, 2021 Tudor domain of histone demethylase KDM4B is a reader of H4K20me3, Jie Xiong, 2020

Areas of Focus

Tumor targeted therapy
Epigenetics and signaling pathways in cancer
Identification of new therapeutic targets

Publications

Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer, Jie Xiong*; Wei Zhang*; Feng Li*, 2024
Oncogenic BRAF noncanonically promotes tumor metastasis by mediating VASP phosphorylation and filopodia formation, Jie Xiong*; Xin Zhu*; Lei Wei*; Feng Li*, 2023
Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis, Jie Xiong*; Feng Li*, 2021
Tudor domain of histone demethylase KDM4B is a reader of H4K20me3, Jie Xiong*, 2020

Cancer Therapy Targets Tumor Epigenetics Signaling Pathways Identification Mechanisms Proteins

Ying Zhao - Peking University

Jing Liang - Peking University

Luyang Sun - Peking University

View All

Personal Information